Dagfinn Lovhaug

Title: Dagfinn Lovhaug: Innovator in Pharmaceutical Imaging

Introduction

Dagfinn Lovhaug is a notable inventor based in Oslo, Norway. He has made significant contributions to the field of pharmaceutical imaging, holding a total of four patents. His work focuses on developing innovative contrast agents and pharmaceutical compounds that enhance diagnostic imaging procedures.

Latest Patents

Among his latest patents, Lovhaug has developed a contrast agent characterized by the general formula (I): Z-L-V-Z(I). This agent includes at least one of Z1 and Z2, which are reporter moieties detectable in in vivo imaging of the human or animal body. The formula also features V as a targeting moiety with binding affinity for areas of collagen formation, and L as a covalent bond, biomodifier, or linker moiety. Additionally, he has created a pharmaceutical compound represented by the formula Z—(L)-V. In this compound, V denotes an amino acid sequence X-X-Val-Tyr-Ile-His-Pro-X-X-X, while L represents a bond or linker. Z can carry an imaging moiety M, enhancing its utility in diagnostic imaging.

Career Highlights

Throughout his career, Dagfinn Lovhaug has worked with prominent companies in the healthcare sector, including GE Healthcare AS and Amersham Health AS. His experience in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to advancements in medical imaging technologies.

Collaborations

Lovhaug has collaborated with several professionals in his field, including Morten Eriksen and Hege B. Fjerdingstad. These collaborations have fostered a productive environment for innovation and development in pharmaceutical imaging.

Conclusion

Dagfinn Lovhaug's contributions to the field of pharmaceutical imaging through his patents and collaborations highlight his role as a significant innovator. His work continues to impact the way diagnostic imaging is approached in the medical field.